Part D Pricing and Subpoena Power: What the November Elections Could Mean for Wall Street
This article was originally published in RPM Report
Executive Summary
The pharmaceutical industry has a lot riding on the mid-term elections: the Democrats only need to take back one chamber of Congress to do damage on Wall Street.